Pew Commends Senators Gillibrand and Feinstein for Working to Shine Light on Antibiotics Practices

Navigate to:

Pew Commends Senators Gillibrand and Feinstein for Working to Shine Light on Antibiotics Practices

The Senate Health, Education, Labor and Pensions Committee today adopted the Animal Drug User Fee Act, which failed to include provisions from Senators Kirsten Gillibrand (D-NY) and Dianne Feinstein (D-CA) that would improve the Food and Drug Administration's annual reporting of antibiotic sales for use on industrial farms. The following statement should be attributed to Laura Rogers, project director for the campaign on Human Health and Industrial Farming, The Pew Charitable Trusts.

We are extremely disappointed with the Senate HELP Committee. Though it is charged with protecting the public's health, it failed to seize its best opportunity to shine more light on practices that are breeding drug-resistant bacteria.Laura Rogers, Pew Campaign on Human Health and Industrial Farming

"We applaud Senators Kirsten Gillibrand (D-NY) and Dianne Feinstein (D-CA) for leading the way on this issue. Their proposal to increase the transparency of antibiotic use on industrial farms would have shed much needed light on practices that threaten our health. The Animal Drug User Fee Act is our best chance to address this challenge, and we will work with them as the bill moves to the Senate floor to ensure that we do not miss this opportunity." 

 

The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life.

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.